Patients with metastatic thyroid cancer (MTC) was routinely treated with a small dose of ^(131)I before 1989. After that we have been switched to multiple courses of large dose ^(131)I therapy. In this paper, the ther...Patients with metastatic thyroid cancer (MTC) was routinely treated with a small dose of ^(131)I before 1989. After that we have been switched to multiple courses of large dose ^(131)I therapy. In this paper, the therapeutic result and its effect, in particular on bone marrow depression, pulmonary, parathyroid and salivary gland function as well as chromosome aberration^(1-3) were observed and reported.展开更多
文摘Patients with metastatic thyroid cancer (MTC) was routinely treated with a small dose of ^(131)I before 1989. After that we have been switched to multiple courses of large dose ^(131)I therapy. In this paper, the therapeutic result and its effect, in particular on bone marrow depression, pulmonary, parathyroid and salivary gland function as well as chromosome aberration^(1-3) were observed and reported.
